Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07824635

Neurobiology of Pain in Burn Survivors

Many burn survivors experience persistent, disabling pain that is strongly influenced by pain catastrophizing, a pattern of negative cognitive and emotional responses to pain involving feelings of helplessness, rumination, and magnification of symptoms. The primary purpose of this study is to evaluate whether an 8-week, remotely delivered cognitive-behavioral therapy program reduces pain interference (disruption to daily life) and pain catastrophizing more effectively than an 8-week pain education. Researchers also aim to identify the neurobiological mechanisms through which non-pharmacologic pain management works using functional Magnetic Resonance Imaging brain scans.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Pain is particularly prevalent (>50%) and disabling following burn injuries. Chronic pain is strongly modulated by negative affect, and pain catastrophizing, a pain-specific psychosocial construct comprising helplessness, pessimism, rumination, and magnification about pain-related symptoms, is a critical predictor of pain severity and treatment satisfaction. Non-pharmacologic interventions such as Cognitive Behavioral Therapy (CBT) improve pain partially by reducing catastrophizing. However, the underlying neurobiology supporting catastrophizing in burn injury survivors remains understudied. Identifying objective, catastrophizing-linked neural biomarkers may serve as important therapeutic targets and predict clinical treatment response.

This study is a randomized, longitudinal neuroimaging trial evaluating the mechanisms of CBT compared to an active educational control. Participants with chronic burn pain are randomized in a 1:1 ratio to undergo one of two 8-week, remotely delivered interventions:

  • CBT: Features 8 weekly 60-minute virtual sessions using active, structured cognitive-behavioral techniques. The intervention focuses on acquiring and practicing cognitive and emotional modulatory skills (e.g., relaxation, thought-stopping, distraction, cognitive restructuring) to reduce maladaptive pain-related cognitions.
  • Pain Education (EDU): An active control condition matched for professional contact time, consisting of 8 weekly virtual sessions covering general pain-related topics (e.g., Gate-Control Theory, pain types) without active pain-coping skill acquisition or home practice.

Assessments and Imaging:

Assessments take place at baseline, 8 weeks (post-intervention), and 24 weeks (follow-up).

  • Neuroimaging: Participants undergo 3-Tesla brain MRI sessions at baseline and 8 weeks, including structural MRI, resting-state fMRI, and a pain catastrophizing fMRI task.
  • fMRI Task: Patients view and reflect on statements from the Pain Catastrophizing Scale (PCS) intermixed with matched neutral statements in a block design during functional scanning.
  • Sensory and Clinical Measures: Baseline visits include Quantitative Sensory Testing (QST) via cuff pressure algometry.
  • Validated questionnaires are administered at all timepoints to measure pain interference (Brief Pain Inventory), catastrophizing (PCS), coping, self-efficacy, and general psychosocial functioning (PROMIS-29).

Study Aims

  • Aim 1: Investigate the association between brain processing of catastrophizing and individual differences in pain intensity and interference among burn-injury survivors. H1.1: Patients with more burn-associated pain and worse interference will show greater catastrophizing-induced activation in posterior cingulate cortex (PCC). H1.2: Patients with more pain and interference will also show greater catastrophizing-induced connectivity between PCC and salience network regions, such as anterior mid-cingulate cortex (aMCC).
  • Aim 2: Evaluate whether CBT (compared to pain education (EDU)) results in greater improvement in pain and catastrophizing, and reduced brain response to catastrophizing cues. H2.1: Patients randomized to CBT, compared to EDU, will report greater reductions in pain interference and catastrophizing. H2.2: Patients randomized to CBT, compared to EDU, will show greater reduction in PCC responses to catastrophizing cues. H2.3: Greater reduction in catastrophizing will be correlated with greater reduction in PCC responses.
  • Aim 3: Determine whether baseline PCC response to catastrophizing cues (after controlling for patient-reported catastrophizing scores) predicts improvement in pain outcomes following CBT, and whether changes in PCC catastrophizing response mediate changes in pain outcomes. H3.1: Based on our preliminary data, greater aMCC activation and PCC-to-aMCC connectivity response to catastrophizing cues at baseline will predict greater reductions in pain interference and catastrophizing following CBT (but not EDU). H3.2: Change in catastrophizing cue PCC responses following therapy will mediate the improvements in pain interference following CBT (versus EDU).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Previously hospitalized for burn injury
  • Age 18 to 65 years
  • Able to provide written informed consent and fluent in English
  • Living in a community setting
  • Six (6) months or more post-burn injury
  • Burn-related pain rated as ≥4 (on a scale of 0-10) over the past week, co-localized with the site of the burn injury

Exclusion criteria

  • Comorbid acute pain condition.
  • Comorbid chronic pain condition that is rated by the participant as more painful than the burn injury pain.
  • Living in an institution or medical facility.
  • Pregnant or nursing.
  • Any psychiatric condition precluding study participation, such as a disorder involving psychosis (e.g., schizophrenia), unmanaged bipolar disorder, or a severe personality disorder.
  • History of anxiety disorders or significant anxiety symptoms interfering with imaging procedures (e.g., panic).
  • Contraindication to MRI (e.g., implanted ferrous metal).
  • History of significant head injury (e.g., with substantial loss of consciousness).
  • Psychiatric hospitalization in the past 6 months.
  • Currently participating in therapeutic clinical research trials.

Treatment and study plan

Cognitive behavioral therapy

Behavioral

An 8-week, remotely delivered behavioral intervention administered weekly via secure video conferencing by a trained psychologist (approximately 60 minutes per session). It utilizes active, structured techniques (such as relaxation, thought-stopping, distraction, and cognitive restructuring) along with in-vivo and home practice to target and reduce maladaptive pain-related cognitions (i.e., pain catastrophizing).

Pain education

Behavioral

An 8-week, remotely delivered educational control intervention administered weekly via secure video conferencing by a trained psychologist (approximately 60 minutes per session). Matched for therapist contact time with the Cognitive Behavioral Therapy group, sessions cover standard pain-related topics (e.g., Gate-Control Theory, types of chronic pain, working with healthcare providers) without active skill-building components, handouts, or at-home practice.

Primary outcomes

  1. fMRI Measure

    Time frame: Baseline and 8 weeks (post-intervention).

    Participants will undergo functional MRI scan sessions, including resting-state fMRI and task-based BOLD fMRI. Task-based fMRI utilizes a block-design contrasting 6 Pain Catastrophizing Scale statements (covering helplessness, magnification, and rumination) against 6 lexically matched neutral control statements.

Secondary outcomes

  1. Pain Catastrophizing Scale (PCS)

    Time frame: Baseline, 8 weeks (post-intervention), and 24 weeks (follow-up).

    The Pain Catastrophizing Scale (PCS) will be used to evaluate negative cognitive-emotional responses to pain across three subscales: helplessness, magnification, and rumination. Scores range from 0 to 52, with higher scores indicating greater pain catastrophizing (worse outcome).

  2. Brief Pain Inventory (BPI)

    Time frame: Baseline, 8 weeks (post-intervention), and 24 weeks (follow-up)

    Measured using the Brief Pain Inventory (BPI) Pain Interference subscale. Evaluates how pain impacts daily activities, mood, mobility, work, relationships, sleep, and enjoyment of life on a scale of 0 to 10, where higher scores indicate greater pain interference (worse outcome).

Other outcomes

  1. Patient-Reported Outcomes Measurement Information System (PROMIS-29)

    Time frame: Baseline, 8 weeks (post-intervention), and 24 weeks (follow-up).

    Measured using the 29-item Patient Reported Outcomes Measurement Information System (PROMIS-29). Evaluates sub-scores for physical function, fatigue, sleep disturbance, social participation, depression, and anxiety.

  2. Quantitative Sensory Testing (QST) Battery

    Time frame: Baseline, and 8 weeks (post-intervention).

    An in-person somatosensory assessment utilizing calf cuff pressure algometry to evaluate individual pain thresholds (mild, moderate, and high pain) as well as dynamic pain mechanisms, including temporal summation of pain and conditioned pain modulation.

  3. Coping Strategies Questionnaire & Pain Self-Efficacy Scale

    Time frame: Baseline, 8 weeks (post-intervention), and 24 weeks (follow-up)

    Assesses cognitive and behavioral coping mechanisms (such as distraction) alongside participant self-efficacy and confidence in engaging in daily activities while managing chronic pain.

  4. Working Alliance Inventory (WAI)

    Time frame: 8 weeks (post-intervention).

    Evaluates the strength, collaborative quality, and therapeutic bond formed between the participant and the interventionist.

Study contacts

Contact information is provided by the study sponsor or research team.

Jeffrey C. Schneider, MD

CONTACT

[email protected]

6179526329

Sponsors and collaborators

Lead sponsor

Spaulding Rehabilitation Hospital

Other

Registry information

Official study title

Neurobiology of Pain in Burn Survivors: Identification and Targeting of a Critical Treatment Mechanism

Important dates

Study start
2027
Primary completion
2031
Study completion
2031
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.